Lanean...
Lessons in precision oncology from neoadjuvant endocrine therapy trials in ER+ breast cancer
For post-menopausal women with clinical stage II/III estrogen receptor positive (ER+) breast cancer neoadjuvant endocrine therapy (NET) is an under-utilized and low-toxicity alternative to chemotherapy for increasing breast conservation rates. Individual responses to endocrine therapy can also be us...
Gorde:
| Argitaratua izan da: | Breast |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5592154/ https://ncbi.nlm.nih.gov/pubmed/28669712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2017.06.039 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|